SCHEMBL7050436

SCHEMBL7050436

NC(=O)c1cccc(OCc2ccccc2)c1-c1ccccc1S(N)(=O)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.49
HTT P42858 1/20 0.49
PTGER1 P34995 2/20 0.47
KEAP1 Q14145 1/20 0.45
NFE2L2 Q16236 1/20 0.45
SIRT2 Q8IXJ6 2/20 0.44
MCL1 Q07820 1/20 0.44
PPIA P62937 1/20 0.42
SGMS2 Q8NHU3 2/20 0.42
DHODH Q02127 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA3 P07451 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA13 Q8N1Q1 1/20 0.41
CA14 Q9ULX7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL875475 0.81 PARP1 (0.60) PARP1HTTPTGER1SIRT2SGMS2
Hydrochloric Acid SCHEMBL27966084 0.79 PARP1 (0.58) PARP1HTTPTGER1SIRT2SGMS2
SCHEMBL875473 0.76 PTGER1 (0.62) PARP1HTTPTGER1SIRT2MCL1
SCHEMBL1013565 0.76 CA1 (0.56) HTTPPIACA12CA1CA2
SCHEMBL718082 0.76 PARP1 (0.79) PARP1HTTSGMS2NPC1MEN1
SCHEMBL7689226 0.74 PARP1 (0.61) PARP1HTTPTGER1SIRT2SGMS2
SCHEMBL30310231 0.73 LTA4H (0.51) PTGER1PPIASGMS2CA12CA1
SCHEMBL7050569 0.72 L3MBTL1 (0.62) SGMS2TDP1L3MBTL1NPC1MEN1
Hydrochloric Acid SCHEMBL28731405 0.71 PARP1 (0.58) PARP1HTTPTGER1SIRT2SGMS2
SCHEMBL173603 0.71 SCN9A (0.47) KEAP1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030191323-A1 Hypoglycemic agent AJINOMOTO CO., INC. (JP) 2003-10-09 US disclosed
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed
EP-1300142-A1 HYPOGLYCEMICS Ajinomoto Co., Inc. (JP) 2003-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN PARP1 4119/4885HTT 2114/4885PTGER1 2189/4885
US-20030191323-A1 Hypoglycemic agent GPR119, IAPP, SLC5A2 PARP1 3553/4885HTT 1374/4885PTGER1 3187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.